Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Malladi Drugs and Pharmaceuticals is a leading Indian manufacturer of active pharmaceutical ingredients (APIs), especially for cough/cold medications such as ephedrine and pseudoephedrine. The company also produces APIs for antihistamines, CNS drugs including anti-convulsants and anxiolytics. It operates globally with regulatory approvals from US FDA, EDQM, TGA Australia among others. The company is not a clinical-stage innovator but rather a commercial supplier of generic APIs[1][3][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Malladi Drugs and Pharmaceuticals.